W dniach od 2 kwietnia do 5 kwietnia 2024 r. prowadzone będą prace związane z wdrożeniem nowej wersji systemu Repozytorium UJ. Nie będzie możliwe wprowadzanie nowych informacji do repozytorium. Za utrudnienia przepraszamy.
Determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations using derivative spectrophotometry and chromatographic-densitometric method
Determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations using derivative spectrophotometry and chromatographic-densitometric method
Determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations using derivative spectrophotometry and chromatographic-densitometric method
Two methods, spectrophotometric and chromatographic-densitometric ones, were developed for determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations. Spectrophotometric method involved derivative spectrophotometry and zero order spectrophotometry. The measurements were carried out at λ = 224.0 nm for quinapril, λ = 261.0 nm for hydrochlorothiazide and λ = 270.0 nm for losartan when the derivative spectrophotometry was applied and λ = 317.0 nm when zero order spectrophotometry was applied for the determination of hydrochlorothiazide. In chromatographic-densitometric studies high performance thin layer chromatography (HPTLC) plates were used as stationary phase and a mixture of solvents n-butanol : acetic acid : water (15 : 5 : 1, v/v/v) as mobile phase. Under the established conditions good resolution of examined constituents was obtained. Retardation factor for quinapril hydrochloride was Rf ~ 0.70, for losartan potassium Rf ~ 0.85 and for hydrochlorothiazide Rf ~ 0.78. The developed methods are characterized by high sensitivity and accuracy. For quantitative analysis, densitometric measurements were carried out at λ = 218.0 nm for quinapril, λ = 275.0 nm for hydrochlorothiazide and λ = 232.0 nm for losartan.
pl
dc.subject.en
quinapril
pl
dc.subject.en
losartan
pl
dc.subject.en
hydrochlorothiazide
pl
dc.subject.en
derivative spectrophotometry
pl
dc.subject.en
HPTLC
pl
dc.description.volume
70
pl
dc.description.number
6
pl
dc.description.points
15
pl
dc.identifier.eissn
2353-5288
pl
dc.title.journal
Acta Poloniae Pharmaceutica. Drug Research
pl
dc.language.container
eng
pl
dc.date.accession
2015-10-20
pl
dc.affiliation
Wydział Farmaceutyczny : Zakład Chemii Nieorganicznej
pl
dc.affiliation
Wydział Farmaceutyczny : Zakład Chemii Analitycznej
pl
dc.subtype
Article
pl
dc.rights.original
CC-BY-NC; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0